Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis
-
Published:2024-05
Issue:
Volume:82
Page:82-91
-
ISSN:0924-977X
-
Container-title:European Neuropsychopharmacology
-
language:en
-
Short-container-title:European Neuropsychopharmacology
Author:
Guirguis AORCID,
Chiappini SORCID,
Papanti P GD,
Vickers-Smith R.ORCID,
Harris DORCID,
Corkery JMORCID,
Arillotta DORCID,
Floresta G.ORCID,
Martinotti G,
Schifano F
Funder
Swansea University
Reference75 articles.
1. GLP-1 for type 2 diabetes;Ahrén;Exp. Cell Res.,2011
2. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior;Anderberg;Physiol. Behav.,2014
3. GLP-1 receptor agonists and related mental health issues; insights from a range of social media platforms using a mixed-methods approach;Arillotta;Brain Sci.,2023
4. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017
5. The possible role of prescribing medications, including central nervous system drugs, in contributing to male-factor infertility (MFI): assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database;Baldini;Brain Sci.,2023
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献